Resources

Dr Mahony will work with the UK Government to champion investment into the UK’s innovative life sciences and biotech sector, including playing a key role in the ongoing pension reforms led by Chancellor Rachel Reeves MP.

The Chancellor’s Autumn Budget placed life sciences at the forefront of the UK’s growth agenda, providing key support for R&D tax relief, medicines manufacturing, and sector-specific financing through the British Business Bank.

Mayer Schreiber, CEO of Discovery Park, comments after the historic budget.

In his latest blog, Dr Martin Turner, BIA’s Associate Director of Policy, Public Affairs & Investor Relations, explores the Chancellor’s Autumn Budget 2024, which prioritises life sciences as a key growth driver within the UK economy. Martin provides an insightful breakdown of the measures, from R&D tax relief to funding boosts in manufacturing and biotech. Read on to discover the budget highlights and what they mean for life sciences in the UK.

Read our statement welcoming the Chancellor's recommitment to R&D tax credits, new funding initiatives, and sustained support for biotechnology and medical science.

The first Budget of the new government will be presented this Wednesday. It’s an important moment, not just for life sciences but for the broader UK economy. Read this blog for an update on the Life Sciences Council, and the launch of our latest Influencing and shaping our sector report.

Read today's blog to learn about our latest reports, upcoming events and our CEO's thoughts on the upcoming budget.

The UK biotech sector secured an impressive £808 million in Q3 2024, defying tough global market conditions and demonstrating sustained investor confidence. Read our latest report to find out more.

A new group of MPs and peers, with the support of the BioIndustry Association (BIA), has written to the Chancellor, urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget.

Today marks a pivotal moment for our Association as a key strategic objective has been realised: the new government has placed growth at the centre of its agenda, with life sciences positioned as a cornerstone of that plan.

In this blog, Izzy Webb outlines why the UK has published voluntary guidance to promote synthetic nucleic acid screening and who the guidance is intended for.

In this insightful blog, Louis Taylor, CEO of the British Business Bank, explores how the Mansion House reforms and increased pension fund investments could unlock billions in domestic capital, fueling the next generation of UK innovators.

Steve Bates OBE, CEO of the BIA, responded to the announcement of a new Regulatory Innovation Office.

The government's plan to put life sciences up in lights this Sunday ahead of the International investment Summit was somewhat overtaken by the news of the reorganisation of Keir Starmer's Number 10 team which dominated headlines. Nevertheless, it's been a busy week of announcements affecting our sector.

The BIA’s policy and public affairs team attended the conferences of the three major UK parties this year. This is a key point in the political calendar and allows us to highlight the sector through fringe events, meet policymakers, and get a sense of the political environment.

The shape of the political landscape that our sector will navigate this year became clear at the Labour Party conference in Liverpool last week. The new Labour government will unveil its industrial strategy, hold a Global Investment Summit, and meet with the Life Science Council before the key moment of the Budget on 30 October.